Salivary Gland Cancer

Salivary gland cancer is a type of cancer that starts in the glands that make saliva. These glands are found in your mouth, cheeks, and under your tongue. This cancer can affect any of these glands and can sometimes spread to other parts of the body.

Condition

What people with Salivary Gland Cancer report

Every report comes from a Lived member, sent anonymously.

Have you tried Radiation Therapy for Salivary Gland Cancer?

NameHow it went

About Salivary Gland Cancer

What It Is

Salivary gland cancer is a rare cancer that starts in the glands that make saliva. The largest of these, the parotid glands, sit in front of and just below each ear. Two other pairs lie below the jaw (submandibular glands) and under the tongue (sublingual glands), and hundreds of tiny minor glands line the mouth, nose, sinuses and throat. It is one of the head and neck cancers, but it behaves quite differently from the more familiar cancers of the mouth and throat. Not every salivary gland tumor is cancer. More than half are benign, meaning they do not spread, and most tumors of any kind start in the parotid gland. The odds change with location: roughly one in five parotid tumors is cancer, compared with about half of tumors in the roof of the mouth and nearly all tumors of the sublingual gland. The most common sign is a lump, usually painless, near the ear, in the cheek or jaw, under the chin or inside the mouth. Some people notice trouble swallowing or opening the mouth fully. Numbness, weakness on one side of the face or facial pain that does not go away are more concerning, because they suggest a tumor is pressing on or growing into a nerve. Salivary gland cancer is not one disease: there are dozens of types, and some grow slowly for years while others are fast-growing (high-grade) and more likely to spread.

Causes & Risk Factors

For most people, no clear cause is ever found. Risk rises with age, and these cancers are most often diagnosed in people in their 50s and older. Past radiation treatment to the head and neck is the best-established risk factor, especially when the salivary glands were not shielded. Some workplace exposures have also been linked to higher risk, including rubber manufacturing, asbestos mining, plumbing and some types of woodworking. A few rare types are associated with viral infections, such as Epstein-Barr virus, and people with HIV have a higher risk. Smoking is clearly linked to Warthin tumor, a common benign tumor, but studies of smoking and salivary gland cancer have had mixed results. Inherited gene changes rarely cause these cancers directly. Having a risk factor does not mean someone will develop the disease, and many people who do have no known risk factors.

How It's Diagnosed

Evaluation starts with a head and neck examination. A clinician feels the lump and the nearby lymph nodes, looks inside the mouth and checks whether the face moves normally and has normal feeling, since weakness or numbness can mean a nerve is involved. A head and neck surgeon, also called an ear, nose and throat (ENT) specialist, often takes over from here and may use a thin camera to look at the throat. Imaging shows the tumor's size and how it relates to surrounding structures. Ultrasound is often used for the parotid and submandibular glands, while MRI and CT scans give more detail about depth, nerves and lymph nodes. A PET scan may be used to check for spread elsewhere in the body. Only a tissue sample can tell whether a tumor is benign or cancer, and which type it is. The most common method is fine needle aspiration, in which a thin needle draws cells from the lump, often guided by ultrasound. A core needle biopsy takes a slightly larger sample. When a needle sample is not conclusive, the tumor may be removed and examined in full. Because there are so many types and some look alike under a microscope, it is reasonable to ask that the sample be reviewed by a pathologist experienced with salivary gland tumors. Once cancer is confirmed, staging describes how large the tumor is and whether it has reached nearby tissue, lymph nodes in the neck or distant organs such as the lungs. The tumor's grade, a measure of how abnormal and fast-growing the cells look, is reported alongside the stage, and together they guide treatment.

Treatment Options

Treatment depends on the type of cancer, its grade and stage, where it started, and the person's overall health and preferences. Because these cancers are uncommon, people tend to do better at centers with a lot of experience treating head and neck cancer, where surgeons, radiation and medical oncologists, dentists, speech therapists and dietitians plan care together. Surgery is the main treatment. The goal is to remove the tumor with a rim of healthy tissue around it. In the parotid gland this is complicated by the facial nerve, which runs through the gland and controls the muscles of facial expression. Many parotid cancers can be removed while keeping the nerve intact. If the cancer has grown into the nerve, part of it may need to be removed, and nerve grafts or other reconstructive procedures can restore some function. When the cancer is high-grade or lymph nodes look involved, the surgeon may also remove lymph nodes in the neck (a neck dissection). Early-stage, low-grade cancers are often cured by surgery alone. Radiation therapy is commonly added after surgery when the risk of the cancer returning is higher, such as with high-grade or large tumors, cancer at the edges of the removed tissue, nerve invasion, lymph node spread or adenoid cystic carcinoma. It is usually given on weekdays for about six to seven weeks. Radiation can also be the main treatment when surgery is not possible, or can be used to relieve pain or other symptoms. Its trade-offs include a sore mouth, changes in taste and lasting dry mouth, so a dental check before treatment is a standard part of preparation. For cancer that has spread or come back, options include chemotherapy, targeted drugs and hormone-blocking drugs, chosen according to testing of the tumor itself. Some salivary gland cancers carry markers such as HER2 (a protein that drives cell growth), the androgen receptor (a hormone receptor) or changes in the NTRK genes that switch on abnormal growth signals, and drugs aimed at those specific targets can control the cancer in some people. Because some advanced salivary cancers grow very slowly, a care team may sometimes recommend watching a stable cancer before starting medicine. Clinical trials are an important option for many people with this rare cancer.

What to Expect

Outlook varies more than with many cancers because the types behave so differently. Cancers found while still confined to the gland have a high chance of long-term control. In US data, about 96% of people with cancer limited to the salivary gland are alive five years after diagnosis, compared with people without the cancer; the figure is about 70% when it has spread to nearby structures or lymph nodes and about 42% when it has spread to distant organs. These are averages that cannot predict any one person's course. Tumors in the parotid gland generally do better than those in the minor glands, and size, grade, nerve involvement and complete removal all matter. Recovery after parotid surgery usually involves a scar in front of the ear that may extend into the neck. If the facial nerve was stretched during surgery, weakness of one side of the face is common at first and often improves over a few months. Some people later develop Frey syndrome, in which the skin over the cheek sweats or flushes while eating, and treatment can reduce it. After radiation, dry mouth, swallowing difficulties and a higher risk of tooth decay can last, which makes ongoing dental care and, for some people, speech and swallowing therapy part of life after treatment. Follow-up visits with examination and imaging continue for years. They are most frequent at first and spread out over time. Long follow-up matters because some types, especially adenoid cystic carcinoma, grow slowly but tend to come back or spread to distant organs many years after the original treatment.

When to Seek Help

Make an appointment if a lump or swelling near the ear, in the cheek or jaw, under the chin or inside the mouth does not go away, or if one side of the face or neck is changing shape. Most such lumps are not cancer, but they should be examined. Contact a clinician promptly if a lump is accompanied by weakness or numbness on one side of the face or facial pain that does not settle, since these can mean a nerve is involved. After treatment, tell your care team right away about a new lump, new facial weakness or numbness, or worsening pain or trouble swallowing, so a possible recurrence can be checked early.

Questions to Ask Your Doctor

  1. 1.Is this tumor likely to be benign or cancer, and what type and grade did the biopsy show?
  2. 2.Has a pathologist with experience in salivary gland tumors reviewed my sample?
  3. 3.How close is the tumor to the facial nerve, and what are the chances surgery will affect how my face moves?
  4. 4.Will I need radiation after surgery, and what can be done to protect my teeth and saliva?
  5. 5.If the cancer is advanced, should my tumor be tested for markers such as HER2, the androgen receptor or NTRK, and are there clinical trials I could join?

Last reviewed • Oct 2026

Educational content, not medical advice.